Skip to main content

Colazal Patient Tips

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on June 7, 2025.

1. How it works

2. Upsides

3. Downsides

If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:

Note: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. View complete list of side effects

4. Bottom Line

Colazal (generic name: balsalazide) is an oral prescription medicine indicated for the treatment of mildly to moderately active ulcerative colitis in people 5 years of age and older. It is classified as an aminosalicylate and is converted to mesalamine, the active drug, in the colon where it has its effect.

5. Tips

6. Response and effectiveness

Adults

Children (5 to 17 years of age)

7. Interactions

Medicines that interact with Colazal may change its effects, affect how long it works, or increase side effects. An interaction between two medications does not always mean that you must stop taking one of the medications; however, sometimes it does. Speak to your doctor about how drug interactions should be managed.

Note that this list is not all-inclusive and includes only common medications that may interact with Colazal. You should refer to the prescribing information for a complete list of interactions. Tell your doctor and pharmcist about all your current medicines and any medicine you start or stop using.

Related/similar drugs

References

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Colazal only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Copyright 1996-2025 Drugs.com. Revision date: June 7, 2025.